G+FLAS LIFE SCIENCES
DEAD

Serial Number

87891581

Owner

G+FLAS Life Sciences

Attorney

Sungyong In

Filing Date

Apr 24, 2018

Add to watchlist:

No watchlists yet
View on USPTO

G+FLAS LIFE SCIENCES Trademark

Serial Number: 87891581 • Registration: 5765205

G+FLAS LIFE SCIENCES is a trademark filed by G+FLAS Life Sciences on April 24, 2018. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

G+FLAS Life Sciences (6 trademarks)

Seoul 08790 , KR

Entity Type: 03

Trademark Details

Filing Date

April 24, 2018

Registration Date

May 28, 2019

First Use in Commerce

October 29, 2018

Published for Opposition

January 15, 2019

Cancellation Date

December 12, 2025

Goods & Services

Genome amplification; Research and development in the pharmaceutical and biotechnology fields; Biochemical research and development; Chemical, biochemical, biological and bacteriological research and analysis; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of new technology for others in the field of genomics and biotechnology; Laboratory research services relating to pharmaceuticals; Medical research; Medical and scientific research in the field of cancer treatment and diagnosis; Pharmaceutical research and development; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific research and development; Scientific research consulting in the field of genetic editing; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancerous diseases; Scientific research in the field of genetics and genetic engineering; Structural and functional analysis of genomes; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Filing History

CANCELLED SEC. 8 (6-YR)
Dec 12, 2025 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 28, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
May 28, 2019 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 20, 2019 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 19, 2019 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Apr 6, 2019 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 6, 2019 AITU
USE AMENDMENT FILED
Mar 20, 2019 IUAF
TEAS STATEMENT OF USE RECEIVED
Mar 20, 2019 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 12, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 15, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jan 15, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 26, 2018 NONP
ASSIGNED TO LIE
Dec 6, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 16, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 6, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 6, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 6, 2018 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Jun 22, 2018 GPRN
PRIORITY ACTION E-MAILED
Jun 22, 2018 GPRA
PRIORITY ACTION WRITTEN
Jun 22, 2018 CPRA
ASSIGNED TO EXAMINER
Jun 18, 2018 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 4, 2018 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 3, 2018 NWOS
NEW APPLICATION ENTERED
Apr 27, 2018 NWAP